Finance

Lists
Why is SVNS up 2.86%?
Dive Deeper
SVNS:LON
Solvonis Therapeutics PLC
GBX 0.11
+2.86%
(+0.0030) 1D
Oct 14, 3:52:31 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for SVNS...
Open
GBX 0.11
High
GBX 0.11
Low
GBX 0.11
Mkt. cap
8.18M
Avg. vol.
24.31M
Volume
0.00
52-wk high
GBX 0.39
52-wk low
GBX 0.10
EPS
-GBX 0.00
Shares outstanding
7.90B
No. of employees
6
Open
GBX 0.11
High
GBX 0.11
Low
GBX 0.11
Mkt. cap
8.18M
Avg. vol.
24.31M
Volume
0.00
52-wk high
GBX 0.39
52-wk low
GBX 0.10
EPS
-GBX 0.00
Shares outstanding
7.90B
No. of employees
6
News stories
From web sources and news partners
About Solvonis Therapeutics PLC
CEO-
Employees6
Founded2017
Headquarters-
SectorBiotechnology
Websitesolvonis.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
213.00K
213.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
699.50K
699.50K
505.50K
505.50K
Operating expense
979.00K
979.00K
718.50K
718.50K
Total operating expenses
979.00K
979.00K
718.50K
718.50K
Operating income
-979.00K
-979.00K
-718.50K
-718.50K
Other non operating income
-
-
-
-
EBT including unusual items
-2.06M
-2.06M
-718.50K
-718.50K
EBT excluding unusual items
-928.00K
-928.00K
-718.50K
-718.50K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.06M
-2.06M
-718.50K
-718.50K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2.00K
2.00K
-
-
Interest expense
-
-
-
-
Net interest expenses
2.00K
2.00K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps